英文名稱 | Clazosentan |
---|---|
中文名稱 | 克拉生坦 |
CAS號 | 180384-56-9 |
分子式 | C25H23N9O6S |
分子量 | 577.57 |
外觀 | Off-white to light yellow powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
規(guī)格 | 庫存 | 目錄價(jià) | 會員專享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無牌價(jià)信息,您可以發(fā)送詢價(jià),我們會盡快給你回復(fù)。 |
英文名稱 | Clazosentan |
---|---|
中文名稱 | 克拉生坦 |
CAS號 | 180384-56-9 |
分子式 | C25H23N9O6S |
分子量 | 577.57 |
外觀 | Off-white to light yellow powder |
儲存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Clazosenta (Ro 61-1790, VML-588 and AXV-034) is a novel and highly potent endothelin A antagonist which improves cerebral blood flow and behavior after traumatic brain injury. Clazosentan is being developed in clinical trials for the treatment of patients with aneurysmal subarachnoid hemorrhage (SAH) by Actelion Pharmaceuticals.Clazosentant decreases and reverses cerebral vasospasm after experimental SAH. Clazosentanthas been shown to reduce vasospasm after aneurysmal subarachnoid hemorrhage (aSAH).